Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1921 AL 1935

Biomarkers in Prodromal Parkinson Disease: a Qualitative Review

Cooper CA, Chahine LM.

J Int Neuropsychol Soc. 2016 Nov;22(10):956-967. doi: 10.1017/S1355617716000503.

Alpha-synuclein structure, functions, and interactions

Emamzadeh FN.

J Res Med Sci. 2016 May 9;21:29. doi: 10.4103/1735-1995.181989. eCollection 2016.

Effects of air pollution on human health and practical measures for prevention in Iran

Ghorani-Azam A, Riahi-Zanjani B, Balali-Mood M.

J Res Med Sci. 2016 Sep 1;21:65. doi: 10.4103/1735-1995.189646. eCollection 2016.

Hallucinations in schizophrenia and Parkinson's disease: an analysis of sensory modalities involved and the repercussion on patients

Llorca PM, Pereira B, Jardri R, Chereau-Boudet I, Brousse G, Misdrahi D, Fénelon G, Tronche AM, Schwan R, Lançon C, Marques A, Ulla M, Derost P, Debilly B, Durif F, de Chazeron I.

Sci Rep. 2016 Dec 1;6:38152. doi: 10.1038/srep38152.

Three Cases of Levodopa-Resistant Parkinsonism After Radiation Therapy

Mehanna R, Jimenez-Shahed J, Itin I.

Am J Case Rep. 2016 Dec 2;17:916-920. doi: 10.12659/ajcr.900537.

The Neural Mechanisms of Meditative Practices: Novel Approaches for Healthy Aging

Acevedo BP, Pospos S, Lavretsky H.

Curr Behav Neurosci Rep. 2016;3(4):328-339. doi: 10.1007/s40473-016-0098-x. Epub 2016 Oct 18.

Multi-dimensional analysis on Parkinson's disease questionnaire-39 in Parkinson's patients treated with Bushen Huoxue Granule: A multicenter, randomized, double-blinded and placebo controlled trial

Li M, Yang HM, Luo DX, Chen JZ, Shi HJ.

Complement Ther Med. 2016 Dec;29:116-120. doi: 10.1016/j.ctim.2016.09.008. Epub 2016 Sep 14.

Effects of mind-body exercises on the physiological and psychosocial well-being of individuals with Parkinson's disease: A systematic review and meta-analysis

Kwok JY, Choi KC, Chan HY.

Complement Ther Med. 2016 Dec;29:121-131. doi: 10.1016/j.ctim.2016.09.016. Epub 2016 Sep 22.

Apomorphine therapy in Parkinson's and future directions

Titova N, Chaudhuri KR.

Parkinsonism Relat Disord. 2016 Dec;33 Suppl 1:S56-S60. doi: 10.1016/j.parkreldis.2016.11.013. Epub 2016 Nov 30.

Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease

Cookson MR.

Biochem Soc Trans. 2016 Dec 15;44(6):1603-1610. doi: 10.1042/BST20160228.

The unconventional G-protein cycle of LRRK2 and Roco proteins

Terheyden S, Nederveen-Schippers LM, Kortholt A.

Biochem Soc Trans. 2016 Dec 15;44(6):1611-1616. doi: 10.1042/BST20160224.

Screening for chemical modulators for LRRK2

Mortiboys H.

Biochem Soc Trans. 2016 Dec 15;44(6):1617-1623. doi: 10.1042/BST20160242.

L'RRK de Triomphe: a solution for LRRK2 GTPase activity?

Nixon-Abell J, Berwick DC, Harvey K.

Biochem Soc Trans. 2016 Dec 15;44(6):1625-1634. doi: 10.1042/BST20160240.

First model of dimeric LRRK2: the challenge of unrevealing the structure of a multidomain Parkinson's-associated protein

Guaitoli G, Gilsbach BK, Raimondi F, Gloeckner CJ.

Biochem Soc Trans. 2016 Dec 15;44(6):1635-1641. doi: 10.1042/BST20160226.

Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review

Recasens A, Perier C, Sue CM.

Front Mol Neurosci. 2016 Nov 21;9:128. doi: 10.3389/fnmol.2016.00128. eCollection 2016.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias